MX375720B - Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol. - Google Patents

Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.

Info

Publication number
MX375720B
MX375720B MX2019002362A MX2019002362A MX375720B MX 375720 B MX375720 B MX 375720B MX 2019002362 A MX2019002362 A MX 2019002362A MX 2019002362 A MX2019002362 A MX 2019002362A MX 375720 B MX375720 B MX 375720B
Authority
MX
Mexico
Prior art keywords
group
formula
compound
preparation
sub
Prior art date
Application number
MX2019002362A
Other languages
English (en)
Other versions
MX2019002362A (es
Inventor
Bjoern Bartels
Dieter Muri
Matthias Koerner
Philipp Cueni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2019002362A publication Critical patent/MX2019002362A/es
Publication of MX375720B publication Critical patent/MX375720B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación del compuesto de fórmula I, (ver Fórmula) comprendiendo el proceso: a) el acoplamiento de un compuesto de fórmula 2 (ver Fórmula) en la que se selecciona un grupo saliente O-SO2-R de entre grupo trifilato, grupo tosilato, grupo mesilato, grupo besilato, grupo nosilato o grupo brosilato, con un ácido borónico, un trifluoroborato o un éster de ácido borónico adecuado, bajo argón y en presencia de un catalizador y una base en un solvente adecuado y después aislar el producto en forma de una sal de adición de ácido, proporcionando el compuesto de fórmula Ia (ver Fórmula) y b) convertir la sal de adición de ácido de fórmula Ia en la que el ácido HX comprende ácidos orgánicos o inorgánicos adecuados en el compuesto de fórmula I (ver Fórmula) mediante tratamiento con por lo menos un equivalente estequiométrico de una base adecuada.
MX2019002362A 2016-09-09 2017-09-04 Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol. MX375720B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16187960 2016-09-09
PCT/EP2017/072062 WO2018046428A1 (en) 2016-09-09 2017-09-04 Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole

Publications (2)

Publication Number Publication Date
MX2019002362A MX2019002362A (es) 2019-06-17
MX375720B true MX375720B (es) 2025-03-04

Family

ID=56936288

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002362A MX375720B (es) 2016-09-09 2017-09-04 Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.

Country Status (17)

Country Link
US (1) US11306093B2 (es)
EP (1) EP3510031B1 (es)
JP (1) JP6997769B2 (es)
KR (1) KR102502701B1 (es)
CN (1) CN109689653B (es)
AR (1) AR109586A1 (es)
AU (1) AU2017324297B2 (es)
BR (1) BR112019004091B1 (es)
ES (1) ES2847903T3 (es)
HR (1) HRP20210145T1 (es)
IL (1) IL265013B (es)
MX (1) MX375720B (es)
PL (1) PL3510031T3 (es)
SG (1) SG11201901983PA (es)
SI (1) SI3510031T1 (es)
TW (1) TWI753009B (es)
WO (1) WO2018046428A1 (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044152A1 (es) * 2003-05-09 2005-08-24 Bayer Corp Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
FR2876377B1 (fr) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
LT2247558T (lt) 2008-02-14 2022-04-11 Eli Lilly And Company Nauji vizualizavimo agentai neurologinės disfunkcijos aptikimui
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
US20110124654A1 (en) 2008-06-11 2011-05-26 Huifen Chen Diazacarbazoles and methods of use
EP2323697A2 (en) 2008-07-24 2011-05-25 Siemens Medical Solutions USA, Inc. Imaging agents useful for identifying ad pathology
US20100056491A1 (en) * 2008-08-29 2010-03-04 Memory Pharmaceuticals Corporation 4'-amino cyclic compounds having 5-ht6 receptor affinity
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
EP2411057B1 (en) 2009-03-23 2020-05-06 Eli Lilly and Company Imaging agents for detecting neurological disorders
US20110183938A1 (en) 2009-12-16 2011-07-28 Genentech, Inc. 1,7-diazacarbazoles and methods of use
US20150368244A1 (en) 2011-01-31 2015-12-24 Genentech, Inc. Diazacarbazoles and methods of use
NZ714502A (en) 2011-07-05 2017-04-28 Vertex Pharma Processes and intermediates for producing azaindoles
JP6034005B2 (ja) * 2011-08-03 2016-11-30 出光興産株式会社 ビスカルバゾール誘導体およびこれを用いた有機エレクトロルミネッセンス素子
NO3055308T3 (es) 2013-10-08 2018-04-21
CA2973648C (en) 2015-02-02 2023-09-26 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
JP6831372B2 (ja) * 2015-09-09 2021-02-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 架橋ピペリジン誘導体

Also Published As

Publication number Publication date
JP2019529401A (ja) 2019-10-17
CN109689653B (zh) 2022-04-12
PL3510031T3 (pl) 2021-05-31
AR109586A1 (es) 2018-12-26
CN109689653A (zh) 2019-04-26
US20190300529A1 (en) 2019-10-03
BR112019004091B1 (pt) 2023-02-14
SI3510031T1 (sl) 2021-03-31
AU2017324297B2 (en) 2021-08-05
TW201811787A (zh) 2018-04-01
TWI753009B (zh) 2022-01-21
WO2018046428A1 (en) 2018-03-15
EP3510031B1 (en) 2020-12-02
ES2847903T3 (es) 2021-08-04
SG11201901983PA (en) 2019-04-29
EP3510031A1 (en) 2019-07-17
HRP20210145T1 (hr) 2021-03-05
KR102502701B1 (ko) 2023-02-23
AU2017324297A1 (en) 2019-03-14
KR20190044648A (ko) 2019-04-30
BR112019004091A2 (pt) 2019-05-28
JP6997769B2 (ja) 2022-02-10
IL265013B (en) 2021-09-30
MX2019002362A (es) 2019-06-17
CA3035624A1 (en) 2018-03-15
US11306093B2 (en) 2022-04-19

Similar Documents

Publication Publication Date Title
WO2013184480A3 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
MY175254A (en) Synthesis of lactams
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
IN2012DN03176A (es)
EP4023641A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
NZ701950A (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
WO2014026657A3 (en) A process for the preparation of a derivative of 2-methyl-2'-phenylpropionic acid using new intermediates
WO2012009699A3 (en) Process for preparing antiviral compounds
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
MX2020012083A (es) Metodo de preparacion del inhibidor de alquinilpiridina prolil hidroxilasa.
IN2014DN08732A (es)
MX2019002362A (es) Proceso para preparacion de 2-(6-nitopiridin-3-il)-9h-dipirido[2,3 -beta;3',4'-d]pirrol.
EP2135870A4 (en) Process for production of mirtazapine
EP2952501A3 (en) Anti-cancer dibenzocycloheptane derivatives and a catalytic method for dibenzocycloheptane synthesis and allocolchicinoid synthesis
PH12014501704A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
AU2016374914B2 (en) Method for producing benzoxazole compound
BR112015021072A2 (pt) processo de preparação de um monotriflato de isohexídeo, composto químico, processo para fabricação de um composto derivado de um monotriflato de isohexídeo, e, composto derivado
EA201790659A1 (ru) Способ получения сложных эфиров карбоновых кислот в присутствии титансодержащего катализатора
WO2012134102A3 (ko) 노보넨 디에스터 유도체, 이의 제조방법 및 이의 용도
LT2012082A (lt) Nauji fotochrominiai junginiai, jų gamybos būdas ir tarpiniai junginiai jiems gauti
WO2012052939A3 (en) Preparation of bicyclo[2.2.2]octan-2-one compounds
NZ625000A (en) Co-crystals of cyprodinil
UA79607U (ru) Способ получения полимерной серы
WO2014108806A8 (en) A novel process for the preparation of n-(4-nitro-2-sulfamoyl-phenyl)-malonamic acid methyl ester and n-(4-amino-2-sulfamoyl-phenyl)-malonamic acid methyl ester

Legal Events

Date Code Title Description
FG Grant or registration